Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
Immunosuppression is cornerstone treatment of antineutrophil cytoplasmic antibody associated vasculitis (AAV) but is later complicated by infection, cancer, cardiovascular and chronic kidney disease. Caveolin-1 is an essential structural protein for small cell membrane invaginations known as caveola...
Main Authors: | Sourabh Chand, Julia U Holle, Marc Hilhorst, Matthew J Simmonds, Stuart Smith, Lavanya Kamesh, Peter Hewins, Amy Jayne McKnight, Alexander P Maxwell, Jan Willem Cohen Tervaert, Stefan Wieczorek, Lorraine Harper, Richard Borrows |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3716813?pdf=render |
Similar Items
-
Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
by: Sunil Kapur, et al.
Published: (2021-01-01) -
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
by: Noah Huizenga, et al.
Published: (2020-04-01) -
Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
by: T V Beketova
Published: (2018-05-01) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
by: Saket Jha, et al.
Published: (2019-01-01) -
Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
by: Durga Prasanna Misra, et al.
Published: (2019-01-01)